Our valve is designed to drive favorable patient outcomes through procedural excellence and sustained hemodynamics over time.
Specifically developed to enhance procedural consistency, the cusp overlap technique facilitates implant depth accuracy1 and predictable valve deployment. Additional procedural techniques such as flush port at 3 o'clock help to achieve commissural alignment that may facilitate future coronary access.2
Future coronary access is feasible with the Evolut platform. See how you can keep future treatment options open by leveraging the design of the valve frame and following our procedural techniques.2
The Evolut TAVR platform is built on the original CoreValve™ platform, which pioneered the design elements that enable excellent hemodynamic performance. See how we designed for durability.
TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.
Grubb KJ. An Optimized TAVR Care Pathway Using Evolut PRO and PRO+ Early Results From the Optimize PRO Study. Presented at SCAI Virtual Scientific Sessions; April 28-May 1, 2021.
Tang GHL, Zaid S, Fuchs A, et al. Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap. JACC Cardiovasc Interv. May 11, 2020;13(9):1030–1042.